{"id":235129,"date":"2026-04-13T23:48:36","date_gmt":"2026-04-14T04:48:36","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/04\/minimally-invasive-ablation-can-treat-small-kidney-tumors"},"modified":"2026-04-13T23:48:36","modified_gmt":"2026-04-14T04:48:36","slug":"minimally-invasive-ablation-can-treat-small-kidney-tumors","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/04\/minimally-invasive-ablation-can-treat-small-kidney-tumors","title":{"rendered":"Minimally Invasive Ablation Can Treat Small Kidney Tumors"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/minimally-invasive-ablation-can-treat-small-kidney-tumors.jpg\"><\/a><\/p>\n<p>Among patients with T1a renal cell carcinoma (T1a RCC), ablation and surgical resection showed comparable risks for tumor progression. However, ablation was associated with higher rates of local recurrence but fewer complications and shorter hospital stays than resection or nephrectomy.<\/p>\n<hr>\n<p>\u201cFollow-up data revealed that most local recurrences in patients who underwent ablation were successfully treated with additional ablation or surgery,\u201d the authors wrote.<\/p>\n<p>\u201c[T]his study suggests ablation as a less invasive alternative to surgery for patients with T1a RCC, resulting in a similar high level of oncologic control,\u201d they added.<\/p>\n<p>This study was led by Johanne Ahrenfeldt, PhD, MScEng, Aarhus University Hospital, Denmark. It was <a href=\"https:\/\/pubs.rsna.org\/doi\/10.1148\/radiol.251485\" rel=\"nofollow\" target=\"_blank\">published online<\/a> in <em>Radiology<\/em>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Among patients with T1a renal cell carcinoma (T1a RCC), ablation and surgical resection showed comparable risks for tumor progression. However, ablation was associated with higher rates of local recurrence but fewer complications and shorter hospital stays than resection or nephrectomy. \u201cFollow-up data revealed that most local recurrences in patients who underwent ablation were successfully treated [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-235129","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=235129"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235129\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=235129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=235129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=235129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}